BRCA1 physically associates with p53 and stimulates its transcriptional activity
- PMID: 9582019
- DOI: 10.1038/sj.onc.1201932
BRCA1 physically associates with p53 and stimulates its transcriptional activity
Abstract
Mutations of the BRCA1 tumor suppressor gene are the most commonly detected alterations in familial breast and ovarian cancer. Although BRCA1 is required for normal mouse development, the molecular basis for its tumor suppressive function remains poorly understood. We show here that BRCA1 increases p53-dependent transcription from the p21WAF1/CIP1 and bax promoters. We also show that BRCA1 and p53 proteins interact both in vitro and in vivo. The interacting regions map, in vitro, to aa 224-500 of BRCA1 and the C-terminal domain of p53. Tumor-derived transactivation-deficient BRCA1 mutants are defective in co-activation of p53-dependent transcription and a truncation mutant of BRCA1 that retains the p53-interacting region acts as a dominant inhibitor of p53-dependent transcription. BRCA1 and p53 cooperatively induce apoptosis of cancer cells. The results indicate that BRCA1 and p53 may coordinately regulate gene expression in their role as tumor suppressors.
Similar articles
-
The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.Oncogene. 1999 Jan 7;18(1):263-8. doi: 10.1038/sj.onc.1202323. Oncogene. 1999. PMID: 9926942
-
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.Cancer Gene Ther. 2001 Oct;8(10):759-70. doi: 10.1038/sj.cgt.7700366. Cancer Gene Ther. 2001. PMID: 11687899
-
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.Nature. 1997 Sep 11;389(6647):187-90. doi: 10.1038/38291. Nature. 1997. PMID: 9296497
-
Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer.Biochem Biophys Res Commun. 2011 Sep 30;413(3):395-9. doi: 10.1016/j.bbrc.2011.08.098. Epub 2011 Aug 27. Biochem Biophys Res Commun. 2011. PMID: 21893034 Review.
-
BRCA1/P53: Two strengths in cancer chemoprevention.Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188339. doi: 10.1016/j.bbcan.2020.188339. Epub 2020 Jan 7. Biochim Biophys Acta Rev Cancer. 2020. PMID: 31917206 Review.
Cited by
-
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.Mol Cell Biol. 2002 Jun;22(12):4280-92. doi: 10.1128/MCB.22.12.4280-4292.2002. Mol Cell Biol. 2002. PMID: 12024039 Free PMC article.
-
Tumor suppressor p53 is required to modulate BRCA1 expression.Mol Cell Biol. 2000 Oct;20(20):7450-9. doi: 10.1128/MCB.20.20.7450-7459.2000. Mol Cell Biol. 2000. PMID: 11003642 Free PMC article.
-
Regulation of RelA (p65) function by the large subunit of replication factor C.Mol Cell Biol. 2003 Jan;23(2):721-32. doi: 10.1128/MCB.23.2.721-732.2003. Mol Cell Biol. 2003. PMID: 12509469 Free PMC article.
-
Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.Mol Cell Biol. 2001 Jun;21(12):4005-15. doi: 10.1128/MCB.21.12.4005-4015.2001. Mol Cell Biol. 2001. PMID: 11359908 Free PMC article.
-
The ubiquitin E3 ligase activity of BRCA1 and its biological functions.Cell Div. 2008 Jan 7;3:1. doi: 10.1186/1747-1028-3-1. Cell Div. 2008. PMID: 18179693 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous